NUVA stock forecast
Our latest prediction for NuVasive, Inc.'s stock price was made on the March 6, 2018 when the stock price was at 51.04$.
In the short term (2weeks), NUVA's stock price should outperform the market by 1.92%. During that period the price should oscillate between -5.11% and +5.25%.
In the medium term (3months), NUVA's stock price should outperform the market by 0.75%. During that period the price should oscillate between -10.97% and +13.55%.Get email alerts
About NuVasive, Inc.
NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.
At the moment the company generates 1146M USD in revenues.
On its last earning announcement, the company reported a profit of 0.90$ per share.
The book value per share is 15.19$
Three months stock forecastMarch 6, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|